OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial
Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 997-1011
Open Access | Times Cited: 8
Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 997-1011
Open Access | Times Cited: 8
Showing 8 citing articles:
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, et al.
The Lancet (2024) Vol. 404, Iss. 10451, pp. 445-460
Closed Access | Times Cited: 15
Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, et al.
The Lancet (2024) Vol. 404, Iss. 10451, pp. 445-460
Closed Access | Times Cited: 15
A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis
Katarzyna Waligóra-Dziwak, Aleksandra Dańczak‐Pazdrowska, Dorota Jenerowicz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4001-4001
Open Access | Times Cited: 6
Katarzyna Waligóra-Dziwak, Aleksandra Dańczak‐Pazdrowska, Dorota Jenerowicz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4001-4001
Open Access | Times Cited: 6
Severe Atopic Dermatitis With Increasing Daytime Sleepiness Following Nemolizumab Administration: A Case Report
Kenta Horimukai, Misako Kinoshita, Noriko Takahata
Cureus (2025)
Open Access
Kenta Horimukai, Misako Kinoshita, Noriko Takahata
Cureus (2025)
Open Access
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
Allergology International (2025)
Open Access
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
Allergology International (2025)
Open Access
Interleukin antagonists for atopic dermatitis: a new era of therapy
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 549-559
Closed Access | Times Cited: 2
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 549-559
Closed Access | Times Cited: 2
English version of clinical practice guidelines for the management of atopic dermatitis 2024
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
The Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
The Journal of Dermatology (2024)
Closed Access | Times Cited: 1
A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials?
Jonathan I. Silverberg, Selwyn Ho, Raúl Collazo
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3019-3029
Open Access | Times Cited: 3
Jonathan I. Silverberg, Selwyn Ho, Raúl Collazo
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3019-3029
Open Access | Times Cited: 3
Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives
Mitsuhiro Okano, Kengo Kanai, Aiko Oka
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 371-378
Closed Access | Times Cited: 2
Mitsuhiro Okano, Kengo Kanai, Aiko Oka
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 371-378
Closed Access | Times Cited: 2
